Venture Kick support · Healthtech

RheoCarti receives CHF150,000 Venture Kick support

The ETH Zurich spinout is developing a titanium and hydrogel implant surface designed to behave more like natural cartilage.

RheoCarti is advancing an ETH Zurich implant-research project toward preclinical validation.

Veterinary hip replacement is an initial development route before later human joint-replacement work. The financing supports development readiness rather than a marketed clinical product.

Use of funds

Team growth

Manufacturing and quality readiness

Market development

Funding history

Venture Kick support · This roundCHF 150K

Sources

  1. Wie RheoCarti an der ETH ein Hüftimplantat mit künstlichem Knorpel bautstartupnews.ch · Sep 29, 2026
  2. linkedin.com